{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:49:52Z","timestamp":1761864592156,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.urolonc.2023.10.011","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T07:21:29Z","timestamp":1702106489000},"page":"30.e17-30.e23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preoperative C-reactive protein to albumin ratio as a novel prognostic biomarker for the oncological outcomes of radical nephroureterectomy"],"prefix":"10.1016","volume":"42","author":[{"given":"Chan Hoon","family":"Gwak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3867-4778","authenticated-orcid":false,"given":"Jungyo","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bumjin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryn","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalsan","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Gab","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Hyuk","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bumsik","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanjong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2023.10.011_bib0001","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA A Cancer J Clinicians"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0002","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 update","volume":"79","author":"Roupr\u00eat","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0003","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","article-title":"Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Flaig","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0004","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.urology.2009.10.004","article-title":"A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma","volume":"75","author":"Jeldres","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0005","first-page":"585","article-title":"Management of the distal ureter during nephroureterectomy for upper tract urothelial carcinoma: a comprehensive review of literature","volume":"18","author":"Morriss","year":"2021","journal-title":"Urol J"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0006","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1016\/j.ejca.2009.06.016","article-title":"Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients","volume":"45","author":"Lughezzani","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0007","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1464-410X.2008.08003.x","article-title":"Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients","volume":"103","author":"Remzi","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0008","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1200\/JCO.2010.28.4257","article-title":"Tumor-host interactions: a far-reaching relationship","volume":"28","author":"McAllister","year":"2010","journal-title":"JCO"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0009","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ddmec.2005.05.002","article-title":"Host\u2013tumor interactions influencing cancer progression","volume":"2","author":"Fingleton","year":"2005","journal-title":"Drug Discovery Today: Disease Mechanisms"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12894-019-0457-5","article-title":"Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Urol"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0011","doi-asserted-by":"crossref","first-page":"7464","DOI":"10.18632\/oncotarget.10708","article-title":"Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0012","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00345-014-1311-8","article-title":"Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy","volume":"33","author":"Hurel","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0013","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/fon.09.136","article-title":"Role of systemic inflammatory response in predicting survival in patients with primary operable cancer","volume":"6","author":"Roxburgh","year":"2010","journal-title":"Future Oncol"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0014","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fonc.2018.00078","article-title":"The predictive value of inflammation-related peripheral blood measurements in cancer staging and prognosis","volume":"8","author":"Sylman","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0016","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrurol.2011.145","article-title":"C-reactive protein as a biomarker for urological cancers","volume":"8","author":"Saito","year":"2011","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0017","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1207\/S15327914nc392_8","article-title":"Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss","volume":"39","author":"McMillan","year":"2001","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.737155","article-title":"Prognostic role of the C-reactive protein\/albumin ratio in patients with gynecological cancers: a meta-analysis","volume":"11","author":"Fang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0019","first-page":"1","article-title":"Prognostic role of C-reactive protein in urological cancers: a meta-analysis","volume":"5","author":"Zhou","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0020","first-page":"419","article-title":"Youden index and optimal cut-point estimated from observations affected by a lower limit of detection","volume":"50","author":"Ruopp","year":"2008","journal-title":"Biomedical Journal"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0021","unstructured":"Davidson-Pilon, Cameron. lifelines, survival analysis in Python 2023. https:\/\/doi.org\/10.5281\/ZENODO.7883870."},{"key":"10.1016\/j.urolonc.2023.10.011_bib0022","series-title":"Proceedings of the 9th Python in Science Conference","doi-asserted-by":"crossref","first-page":"92","DOI":"10.25080\/Majora-92bf1922-011","article-title":"Statsmodels: econometric and statistical modeling with python","author":"Seabold","year":"2010"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0023","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms","volume":"13","author":"Elinav","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.715234","article-title":"CD8+ T cell exhaustion in cancer","volume":"12","author":"Dolina","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0025","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41430-021-01014-0","article-title":"The prognostic significance of controlling nutritional status (CONUT) score for surgically treated renal cell cancer and upper urinary tract urothelial cancer: a systematic review and meta-analysis","volume":"76","author":"Peng","year":"2022","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0026","article-title":"Controlling nutritional status (CONUT) score as a new indicator of prognosis in patients with hilar cholangiocarcinoma is superior to NLR and PNI: a single-center retrospective study","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0027","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7861\/clinmedicine.9-1-30","article-title":"Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein\/albumin ratio as a predictor of patient outcome","volume":"9","author":"Fairclough","year":"2009","journal-title":"Clin Med"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0028","article-title":"Prognostic role of pretreatment C-reactive protein to albumin ratio in urological cancers: a systematic review and meta-analysis","volume":"12","author":"Wu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0029","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.euo.2020.11.005","article-title":"Incidence and survival rates of contemporary patients with invasive upper tract urothelial carcinoma","volume":"4","author":"Coll\u00e0 Ruvolo","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2023.10.011_bib0030","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1038\/srep06361","article-title":"The impact of tumor location and multifocality on prognosis for patients with upper tract urothelial carcinoma: a meta-analysis","volume":"4","author":"Wu","year":"2014","journal-title":"Sci Rep"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923003460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923003460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:28:09Z","timestamp":1761042489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143923003460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1078143923003460"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.10.011","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative C-reactive protein to albumin ratio as a novel prognostic biomarker for the oncological outcomes of radical nephroureterectomy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}